The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
D000549:Ambenonium Chloride / Q000627:therapeutic use; D002800:Cholinesterase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D002802:Cholinesterases; D004491:Edrophonium / Q000627:therapeutic use; D004798:Enzymes / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D066298:In Vitro Techniques; D009157:Myasthenia Gravis / Q000188:drug therapy*; D009388:Neostigmine / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D004798:Enzymes; D009388:Neostigmine; D000549:Ambenonium Chloride; D004491:Edrophonium; D002802:Cholinesterases; D011729:Pyridostigmine Bromide